165 related articles for article (PubMed ID: 28413414)
1. Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors.
Sverdrup Efjestad A; Ihle-Hansen H; Hjellvik V; Blix HS
Dement Geriatr Cogn Dis Extra; 2017; 7(1):30-40. PubMed ID: 28413414
[TBL] [Abstract][Full Text] [Related]
2. Drug Use before and after Initiating Treatment with Acetylcholinesterase Inhibitors.
Efjestad AS; Ihle-Hansen H; Hjellvik V; Engedal K; Blix HS
Dement Geriatr Cogn Dis Extra; 2019; 9(1):196-206. PubMed ID: 31143200
[TBL] [Abstract][Full Text] [Related]
3. Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database.
Efjestad AS; Ihle-Hansen H; Hjellvik V; Engedal K; Blix HS
Front Pharmacol; 2021; 12():791578. PubMed ID: 35273492
[No Abstract] [Full Text] [Related]
4. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in psychotropic and analgesic drug use before and after initiating treatment with acetylcholinesterase inhibitors.
Efjestad AS; Ihle-Hansen H; Hjellvik V; Engedal K; Salvesen Blix H
PLoS One; 2021; 16(9):e0243804. PubMed ID: 34543268
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic burden of patients with dementia attending a Psychiatry of Later Life service.
Vaughan RM; Flynn R; Greene N
Ir J Psychol Med; 2022 Mar; 39(1):39-44. PubMed ID: 31112109
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study.
Narayan SW; Hilmer SN; Horsburgh S; Nishtala PS
Drugs Aging; 2013 Nov; 30(11):927-34. PubMed ID: 23975730
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson's disease and acetylcholinesterase inhibitors in Parkinson's disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data.
Baik D; Yu YM; Jung SY; Kang HY
BMC Geriatr; 2022 Jul; 22(1):609. PubMed ID: 35864474
[TBL] [Abstract][Full Text] [Related]
9. Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications.
Moo LR; Martinez E; Padala K; Dunay MA; Scali RR; Chen S; Thielke SM
Clin Ther; 2021 Jun; 43(6):942-952. PubMed ID: 34127273
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
[TBL] [Abstract][Full Text] [Related]
11. Adverse outcomes of abrupt switch and discontinuation of acetylcholinesterase inhibitors in dementia with Lewy bodies: Case report and literature review.
Greiman TL; Dear BN; Wilkening GL
Ment Health Clin; 2019 Sep; 9(5):309-314. PubMed ID: 31534872
[TBL] [Abstract][Full Text] [Related]
12. Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia.
Scuteri D; Vulnera M; Piro B; Bossio RB; Morrone LA; Sandrini G; Tamburin S; Tonin P; Bagetta G; Corasaniti MT
Eur J Clin Pharmacol; 2021 Feb; 77(2):241-249. PubMed ID: 32935181
[TBL] [Abstract][Full Text] [Related]
13. Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
Huisa BN; Thomas RG; Jin S; Oltersdorf T; Taylor C; Feldman HH
J Alzheimers Dis; 2019; 67(2):707-713. PubMed ID: 30636733
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia.
Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT
J Am Geriatr Soc; 2019 Sep; 67(9):1871-1879. PubMed ID: 31162642
[TBL] [Abstract][Full Text] [Related]
15. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia.
Masurkar PP; Chatterjee S; Sherer JT; Aparasu RR
Drugs Aging; 2021 Jul; 38(7):593-602. PubMed ID: 34027602
[TBL] [Abstract][Full Text] [Related]
16. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.
Kersten H; Molden E; Willumsen T; Engedal K; Bruun Wyller T
Br J Clin Pharmacol; 2013 Mar; 75(3):842-9. PubMed ID: 22924454
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic Medication Burden in Parkinson's Disease Outpatients.
Nawaz H; Sargent L; Quilon H; Cloud LJ; Testa CM; Snider JD; Lageman SK; Baron MS; Berman BD; Zimmerman K; Price ET; Mukhopadhyay ND; Barrett MJ
J Parkinsons Dis; 2022; 12(2):599-606. PubMed ID: 34806617
[TBL] [Abstract][Full Text] [Related]
18. Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of Medicare beneficiaries from 2007 to 2008.
Palmer JB; Albrecht JS; Park Y; Dutcher S; Rattinger GB; Simoni-Wastila L; Walker LD; Zuckerman IH
Drugs Aging; 2015 Jan; 32(1):79-86. PubMed ID: 25491558
[TBL] [Abstract][Full Text] [Related]
19. Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study.
Martinez C; Jones RW; Rietbrock S
BMJ Open; 2013 Jan; 3(1):. PubMed ID: 23299113
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
